| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
|
Wu, Shuo-Chieh
|
|
2015
|
28 |
1 |
p. 29-41
13 p.
|
artikel
|
| 2 |
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
|
Mohammad, Helai P.
|
|
2015
|
28 |
1 |
p. 57-69
13 p.
|
artikel
|
| 3 |
Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
|
Stewart, C. Allison
|
|
2015
|
28 |
1 |
p. 4-6
3 p.
|
artikel
|
| 4 |
Are Synthetic Compounds that Silence the Liver-X-Receptor the Next Generation of Anti-cancer Drugs?
|
Steffensen, Knut R.
|
|
2015
|
28 |
1 |
p. 3-4
2 p.
|
artikel
|
| 5 |
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
|
McGranahan, Nicholas
|
|
2015
|
28 |
1 |
p. 141-
1 p.
|
artikel
|
| 6 |
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
|
Flaveny, Colin A.
|
|
2015
|
28 |
1 |
p. 42-56
15 p.
|
artikel
|
| 7 |
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms
|
Meyer, Sara C.
|
|
2015
|
28 |
1 |
p. 15-28
14 p.
|
artikel
|
| 8 |
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
|
Goodwin, Jonathan F.
|
|
2015
|
28 |
1 |
p. 97-113
17 p.
|
artikel
|
| 9 |
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
|
Shojaee, Seyedmehdi
|
|
2015
|
28 |
1 |
p. 114-128
15 p.
|
artikel
|
| 10 |
Genetic Classification of Gliomas: Refining Histopathology
|
Foote, Michael B.
|
|
2015
|
28 |
1 |
p. 9-11
3 p.
|
artikel
|
| 11 |
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
|
Yu, Yu
|
|
2015
|
28 |
1 |
p. 82-96
15 p.
|
artikel
|
| 12 |
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
|
Kelderman, Sander
|
|
2015
|
28 |
1 |
p. 11-13
3 p.
|
artikel
|
| 13 |
MYC Is a Major Determinant of Mitotic Cell Fate
|
Topham, Caroline
|
|
2015
|
28 |
1 |
p. 129-140
12 p.
|
artikel
|
| 14 |
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models
|
Zou, Helen Y.
|
|
2015
|
28 |
1 |
p. 70-81
12 p.
|
artikel
|
| 15 |
Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer
|
Wei, Wei
|
|
2015
|
28 |
1 |
p. 7-9
3 p.
|
artikel
|
| 16 |
Targeting the Inactive Conformation of JAK2 in Hematological Malignancies
|
Silvennoinen, Olli
|
|
2015
|
28 |
1 |
p. 1-2
2 p.
|
artikel
|
Tijdschrift beschrijving